✦ LIBER ✦

A 52-week, open-label, dose-titration safety study of imidapril in the treatment of mild to moderate hypertension

✍ Scribed by Ian Dews; Malcolm VandenBurg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open dose titration safety study of imid

✍ DEWS, I 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 214 KB

Comparison of valsartan and irbesartan i

✍ Ettore Malacco; Simona Piazza; Rachele Meroni; Anna Milanesi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 431 KB

An open-label, noncomparative, multicent

✍ Asad Sadick; Muhammad Zahid Yusuf; Michael Reuter 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Safety of irbesartan in the treatment of

✍ Teresa A Simon; R.Thomas Gelarden; Steven A Freitag; Kenneth B Kassler-Taub; Ric 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Open label, multicenter, 28-week extensi

✍ Brian R. Ott; Lesley M. Blake; Ethel Kagan; Malca Resnick; for the Memantine MEM 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB

Safety and Efficacy of Aliskiren/Amlodip

✍ Alexander V. Murray; Wolfgang Koenig; Juan Garcia-Puig; Samir Patel; Alkaz Uddin 📂 Article 📅 2012 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 170 KB